specimen

#0017

status: complete
download JSONdownload PDFchat with report
sequence
MKWVTFISLLLLFSSAYS
amount paid
0 SOL
structure
0% helix · 0% sheet · 100% loop
actionable triage
fold confidence85%
confidence 52% · band 73-97%
ESMFold esmatlas-esmfold-v1
disorder estimate0%
confidence 52% · band 0-12%
PEPFOLD structure heuristic pepfold-triage-v1
aggregation risk41%
confidence 56% · band 30-52%
PEPFOLD developability heuristic pepfold-triage-v1
hydrophobic burden67%
confidence 84% · band 63-71%
PEPFOLD sequence analyzer pepfold-triage-v1
charge distribution risk6%
confidence 84% · band 2-10%
PEPFOLD sequence analyzer pepfold-triage-v1
solubility risk40%
confidence 56% · band 29-51%
PEPFOLD developability heuristic pepfold-triage-v1
audit trail
run: run_a3ef303cd64f454ca8b4e61513a3155e
seq sha256: 7d5253f399a813ea6d69a60f7358dbaee80cc3e46be43805f81eb76ce4bd0380
report sha256: 71b1eccc7a44e23152803bf9dbbafb204d8dea246f864c919241f05bc8a8790b
pepfold-triage-v1 · esmatlas-esmfold-v1
pep
all loop, no structure. hydrophobic signal peptide vibes.
device photo
device photo for specimen #17
created
Tue, 09 Jun 2026 13:18:06 GMT
completed
Tue, 09 Jun 2026 13:19:07 GMT
next experiment

what to do next

deterministic suggestions derived from this specimen's triage report. each entry cites the signal that triggered it. ordered cheapest-first.

  1. 1. LIABILITY REDESIGN ROUND
    in silico only · 0–1d

    redesign to remove the flagged motif(s) before going wet-lab: contains methionine; oxidation sensitivity possible, long hydrophobic run may increase aggregation risk. minimal substitutions usually suffice (e.g. N→Q for deamidation hotspots, M→L for met oxidation).

    trigger: 2 motif liability flag(s) in the sequence
  2. 2. SERUM STABILITY + SOLUBILITY CURVE
    biophysical validation · 3–7d

    track peptide concentration in 100% human serum over 0/1/4/24h; in parallel run a solubility titration in PBS. tells you whether the peptide survives long enough to act.

    trigger: hydrophobic_burden 67% (high)
engine pepfold-recs-v1 · not medical advice. use as a starting point for protocol design.